IASLC WCLC 2020: Addition of sintilimab to pemetrexed and platinum improved progression-free survival in NSCLC
The interim analysis of ORIENT-11, a phase III double-blind randomised trial has shown a nearly…
Browsing: non-squamous non-small cell lung cancer
AACR 2018: Combination therapy doubles survival in metastatic lung cancer
The immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small…